Although Motivational Enhancement Therapy (MET) has emerged as one of the cornerstones of addiction psychosocial treatments, this approach is rarely used by community-based, addiction clinicians. A major barrier to using MET is the fact that the Personalized Feedback component of MET is not community-friendly. Current MET Feedback tools can be complex and require the use of multiple research instruments not used by clinicians, are available only for a single drug problem, and lack normative feedback for drug abuse. We will address these three problems in the First phase of this NIDA Stage I a/b therapy development grant by developing and pilot testing a computer-assisted MET (C-MET) intervention. C-MET will provide clinicians with Personalized Feedback for multiple-drug problems, be based on data from the Addiction Severity Index (ASI), and provide normative data for specific drug problems based on a large ASI database. C-MET is designed for the common community-based clinical problem of poly-drug abuse. Because MET is believed to contain two active ingredients (Personalized Feedback and Motivational Interviewing), a simplified Personalized Feedback (PF) only approach will also be developed and piloted to teach clinicians how to deliver Personalized Feedback alone without MI. In the Second phase of this grant (Stage lb phase) we will then compare the relative efficacy of our C-MET and PF approaches by comparing 4 weeks of C-MET vs. PF vs. Individual Drug Counseling (IDC). This will also serve as a dismantling study that disentangles the effects of Feedback and MI, as well as an opportunity to assess our products, the feasibility of training clinicians in this new approach and its relative effectiveness. Overall this study will facilitate the integration of MET into the community by addressing poly-drug abuse, simplifying MET with computerized Feedback Reports, and assessing whether Personalized Feedback alone can adequately enhance patient engagement and retention without the extensive training requirements for clinicians to adhere and be competent in MI.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
3R01DA015978-04S1
Application #
7161669
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Mcnamara-Spitznas, Cecilia M
Project Start
2002-09-25
Project End
2006-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
4
Fiscal Year
2006
Total Cost
$58,372
Indirect Cost
Name
University of Medicine & Dentistry of NJ
Department
Psychiatry
Type
Schools of Medicine
DUNS #
617022384
City
Piscataway
State
NJ
Country
United States
Zip Code
08854
Williams, Jill M; Gandhi, Kunal K; Steinberg, Marc L et al. (2007) Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res 9:873-81
Yanos, Philip T; Ziedonis, Douglas M (2006) The patient-oriented clinician-researcher: advantages and challenges of being a double agent. Psychiatr Serv 57:249-53
Sussner, Bradley D; Smelson, David A; Rodrigues, Stephanie et al. (2006) The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend 83:233-7
Foulds, Jonathan; Steinberg, Michael B; Williams, Jill M et al. (2006) Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev 25:59-71
Smelson, David A; Ziedonis, Douglas; Williams, John et al. (2006) The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol 26:9-12
Ziedonis, Douglas M; Guydish, Joseph; Williams, Jill et al. (2006) Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health 29:228-35
Williams, Jill M; Ziedonis, Douglas M; Abanyie, Francisca et al. (2005) Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res 79:323-35
Williams, Jill M; Foulds, Jonathan; Dwyer, Martha et al. (2005) The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. J Subst Abuse Treat 28:331-40
Steinberg, Marc L; Williams, Jill M; Steinberg, Howard R et al. (2005) Applicability of the Fagerstrom Test for Nicotine Dependence in smokers with schizophrenia. Addict Behav 30:49-59
Ziedonis, Douglas M (2004) Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectr 9:892-904, 925

Showing the most recent 10 out of 14 publications